Gastroenterology Coding Alert

READER QUESTIONS:

Scheduling Sessions Squelches Most E/Ms

Question: Our gastroenterology practice recently opened an infusion suite on site -- mostly to treat patients with Crohn's disease. Yesterday, an established patient with a treatment plan in place for Plummer-Vinson syndrome secondary to colonic Crohn's reported to the gastroenterologist for a scheduled Remicade infusion and Venofer injection. The gastroenterologist performed a 42- minute, 80 mg Remicade infusion, and also injected 50 mg of Venofer to combat the patient's anemia. What is the correct coding for this encounter? Montana Subscriber Answer: On the claim, report the following: • 96413 (Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug) for the infusion session • J1745 (Injection, infliximab, 10 mg) x 8 for the Remicade supply • 555.1 (Regional enteritis; large intestine) appended to 96413 to represent the patent's Crohn's disease • J1756 (Injection, iron sucrose, 1 mg) x 50 for the Venofer • 280.8 (Iron deficiency anemias; other [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Gastroenterology Coding Alert

View All